Pacific Edge cuts losses by $4.7m on US growth

Pacific Edge cuts losses by $4.7m on US growth
Total lab throughput for tests dipped 6% compared to the prior year.
Brent Melville
Cancer diagnostics firm Pacific Edge has slowed its cash burn on the strength of key wins in its core US market, trimming net losses after tax by a quarter, or $4.7 million, to $14.2m for the year to March.That came off a more than doubling in revenue to $10.4m from a comparable $5.2m in 2020, with operating revenue from test sales at $7.7m, driven by inroads into the commercialisation of its Cxbladder product into international markets.Chief executive David Darling said the result had been achieved despite headwinds created by covid particular...

More Markets

NZ sharemarket falls 1.3% on uncertainty
Markets Market Close

NZ sharemarket falls 1.3% on uncertainty

The S&P/NZX 50 Index closed at 12,249.55, down 161.42 points or 1.3%.

Graham Skellern 12 Mar 2025
Rocket Lab looks to raise up to US$500 million
Markets

Rocket Lab looks to raise up to US$500 million

The money will fund acquisitions and general corporate and working capital purposes.

Rebecca Howard 12 Mar 2025
The who’s who of NZME’s board hopefuls
Markets

The who’s who of NZME’s board hopefuls

Who are the players causing ripples in investor and media circles?

Duke pins recovery hopes on lower interest rates
Retail

Duke pins recovery hopes on lower interest rates

The Briscoe Group chief said he is ‘thrilled to bits’ with the full-year result.

Gregor Thompson 12 Mar 2025